Columbus, OH – The Department of Justice (DOJ) and the state of Ohio have filed a civil antitrust lawsuit against OhioHealth, alleging the Columbus-based health system engaged in practices that stifle competition and drive up healthcare costs. The lawsuit, filed Friday, centers on claims that OhioHealth imposes restrictive contract terms with insurers, limiting patient choice and hindering the development of more affordable healthcare options.
The core of the complaint focuses on what regulators describe as anti-competitive contract provisions, including “anti-steering” clauses and “all-or-nothing” contracting strategies. These provisions, according to the DOJ and Ohio Attorney General’s office, effectively prevent insurance companies from offering plans that prioritize lower-cost providers and limit the ability of other hospitals to negotiate competitive pricing. The goal of the lawsuit is to restore competition in the central Ohio healthcare market and ensure consumers have access to more affordable care.
“Competition for healthcare is vital to all Americans,” stated Omeed Assefi, acting assistant attorney general of the Justice Department’s Antitrust Division, in a press release. “This lawsuit challenges anticompetitive contract restrictions that prevent consumers from choosing lower-cost health plans and severely limit consumers’ access to price information.”
What are Anti-Steering and All-or-Nothing Contracts?
Anti-steering provisions, as alleged in the lawsuit, prevent insurers from incentivizing patients to choose specific hospitals or providers based on cost or quality. Essentially, they restrict an insurer’s ability to guide patients toward more affordable options. All-or-nothing contracts, require insurers to include all of a health system’s hospitals in their network, even if some are significantly more expensive than others. This limits the insurer’s ability to create tiered networks that offer lower premiums in exchange for limited access to certain providers. These practices, regulators argue, effectively give OhioHealth undue market power.
OhioHealth’s Response and the Broader Trend
OhioHealth has not yet issued a detailed public response to the lawsuit. But, the health system acknowledged the legal action in a statement, asserting its commitment to providing high-quality, affordable care to the community. The lawsuit against OhioHealth is part of a growing trend of government scrutiny of non-profit health systems and their market power.
Recently, the Department of Justice and Ohio’s attorney general also accused OhioHealth of driving up prices and crowding out competition, according to Stat News.
Other healthcare organizations have also faced legal challenges related to antitrust concerns. Kaiser Permanente recently reached a $556 million settlement with the DOJ over allegations of Medicare Advantage fraud, the largest of its kind, as reported by Stat News. the DOJ reached a settlement with UnitedHealth regarding its $3.3 billion Amedisys deal (Stat News).
What’s Next?
The lawsuit against OhioHealth is still in its early stages. The legal proceedings will likely involve extensive discovery, including the examination of contracts and internal documents. The outcome of the case could have significant implications for how healthcare systems negotiate with insurers and the extent to which they can control prices in the market. The DOJ’s pursuit of this case signals a continued commitment to enforcing antitrust laws in the healthcare industry, with the aim of promoting competition and lowering costs for consumers.
This represents a developing story. Check back for updates as they become available. Share your thoughts in the comments below.
Disclaimer: This article provides informational content only and is not intended to be a substitute for professional medical or legal advice. Always consult with a qualified healthcare provider or legal professional for any questions you may have regarding your specific situation.
